Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Envista HoldingsNVST +1.32%80 Market Cap is $4,382 Mil as of Jul. 22, 2026. GuruFocus rates NVST with a GF Score™ of 80/100 and a GF Value™ of $23.91 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 865 Medical Devices & Instruments companies, Envista Holdings ranks better than 92.37% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Envista Holdings's share price for the quarter that ended in Mar. 2026 was $25.37. Envista Holdings's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 163 Mil. Therefore, Envista Holdings's market cap for the quarter that ended in Mar. 2026 was $4,133 Mil.
Envista Holdings's quarterly market cap
increased
from Sep. 2025 ($3,361 Mil) to Dec. 2025 ($3,556 Mil) and
increased
from Dec. 2025 ($3,556 Mil) to Mar. 2026 ($4,133 Mil).
Envista Holdings's annual market cap
declined
from Dec. 2023 ($4,126 Mil) to Dec. 2024 ($3,322 Mil) but then
increased
from Dec. 2024 ($3,322 Mil) to Dec. 2025 ($3,556 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Envista Holdings's Enterprise Value for Today is $4,889 Mil.
Envista Holdings (NYSE:NVST) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Envista Holdings Market Cap Related Terms
Envista Holdings Market Cap Historical Data
* Premium members only.
The historical data trend for Envista Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Envista Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Envista Holdings Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Envista Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Envista Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Envista Holdings's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Envista Holdings (NVST) has a Market Cap of $4,382 Mil as of Jul. 22, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Envista Holdings and its competitors. According to the industry distribution chart, Envista Holdings ranks #66 out of 865 companies in the Medical Devices & Instruments industry, placing it in the top 7.6%.
Is Envista Holdings' Market Cap too high?
Envista Holdings' current Market Cap is $4,382 Mil. The Medical Devices & Instruments industry median Market Cap is 111.74. Envista Holdings' value of $4,382 Mil is 3821.5% above this industry median. Based on the distribution chart, Envista Holdings ranks #66 out of 865 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Envista Holdings has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Envista Holdings' Market Cap compare to MMSI and MMED?
According to the Medical Devices & Instruments industry distribution chart, Envista Holdings ranks #66 out of 865 companies for Market Cap. This places Envista Holdings in the top 8% of its industry — outperforming the majority of peers. The industry median Market Cap is 111.74. Envista Holdings' value of $4,382 Mil is 3821.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 111.74, based on 865 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Envista Holdings's current Market Cap of $4,382 Mil is 3821.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Envista Holdings and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 111.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Envista Holdings's current Market Cap is $4,382 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Envista Holdings stock overvalued right now?
Based on GuruFocus' analysis, Envista Holdings (NVST) is currently considered Modestly Overvalued. The stock's GF Value™ is $23.91, compared to a current price of $26.93 — trading 12.6% above its estimated fair value. The current Market Cap is $4,382 Mil and 3821.5% above the Medical Devices & Instruments industry median of 111.74. Envista Holdings' overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Envista Holdings (NVST), the current Market Cap is $4,382 Mil as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Envista Holdings (NVST) Overvalued in 2026?
Based on GuruFocus' analysis, Envista Holdings stock appears to be overvalued.
The current stock price of $26.93 is trading 12.6% above its estimated GF Value™ of $23.91.
GuruFocus considers Envista Holdings to be Modestly Overvalued.
Key valuation signals for NVST:
Market Cap: $4,382 Mil
GF Value™: $23.91 vs. price of $26.93 (12.6% above fair value)
Industry Position: 3821.5% above the Medical Devices & Instruments median (#66 of 865)
No single metric tells the full story. See the NVST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
80GF Score
Get the complete analysis for NVST
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NVST has been successfully added to your 
